Barclays Downgrades Astera Labs (ALAB) to Equalweight

October 20, 2025 3:10 AM EDT Send to a Friend
Barclays analyst Tom O'Malley downgraded Astera Labs (NASDAQ: ALAB) from Overweight to Equalweight with a price target of $155.00.
The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login